Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00721188 · ClinicalTrials.gov registry record · Phase 2
Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients
A Phase 2 study of Anemia, sponsored by American Regent.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT00721188: Completed Phase 2 study of Anemia, sponsored by American Regent.
NCT00721188 is a Phase 2 study of Anemia that has completed, run by American Regent. The registered enrollment target is 11 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00721188, a Phase 2 study of Anemia, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.
Conditions Studied
Interventions
- DRUG Venofer
Study Locations (1)
Pennsylvania
- Luitpold Pharmaceuticals - Norristown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
What the finished NCT00721188 record still lists
NCT00721188 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Venofer is the first listed.
NCT00721188 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00721188 about?
NCT00721188 is a clinical study titled "Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients". The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.
What is the current status of trial NCT00721188?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2006-01. Estimated completion is 2010-01.
What conditions does trial NCT00721188 study?
This clinical trial studies the following conditions: Anemia.
What interventions are being tested in trial NCT00721188?
The interventions under investigation include: Venofer (DRUG).
Who is sponsoring clinical trial NCT00721188?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00721188 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00721188's enrollment target sits among peer trials
11 70th of 72 higher than 3 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
-
Choline and Iron Deficiency
RECRUITING · Phase 2
-
Luspatercept for Clonal Cytopenias of Uncertain Significance
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia